stockrowRepligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Shares outstanding
Repligen Corporation's shares outstanding at the end of fiscal 2025 was $56.6M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $56.6M. Over the past ten years it has ranged from $33.6M (fiscal 2015) to $57.5M (fiscal 2022); the current reading is higher than 82% of that period. Repligen Corporation ranks 27th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $56.6M | 1.12% |
| FY2024 | $55.9M | (0.78%) |
| FY2023 | $56.4M | (1.88%) |
| FY2022 | $57.5M | 0.33% |
| FY2021 | $57.3M | 6.26% |
| FY2020 | $53.9M | 9.52% |
| FY2019 | $49.2M | 8.21% |
| FY2018 | $45.5M | 16.15% |
| FY2017 | $39.2M | 14.81% |
| FY2016 | $34.1M | 1.55% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $56.6M | (0.14%) |
| Jun 2026 | $56.6M | (0.05%) |
| Mar 2026 | $56.7M | 0.19% |
| Dec 2025 | $56.6M | 0.05% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $680.9M |
| BAX Baxter International Inc. compare | $520.0M |
| BLCO Bausch + Lomb Corporation compare | $361.5M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| ALGN Align Technology, Inc. compare | $71.0M |
| ATR AptarGroup, Inc. compare | $64.1M |
| RGEN Repligen Corporation | $56.6M |
| TFX Teleflex Incorporated compare | $43.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement